Cargando…
Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis
Agonists of the transmembrane intestinal receptor guanylyl cyclase C (GCC) have recently attracted interest as promising human therapeutics. Peptide ligands that can specifically induce GCC signaling in the intestine include endogenous hormones guanylin and uroguanylin, diarrheagenic bacterial enter...
Autor principal: | Pitari, Giovanni M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634396/ https://www.ncbi.nlm.nih.gov/pubmed/23637522 http://dx.doi.org/10.2147/DDDT.S32252 |
Ejemplares similares
-
Nucleotidyl Cyclase Activity of Particulate Guanylyl Cyclase A: Comparison with Particulate Guanylyl Cyclases E and F, Soluble Guanylyl Cyclase and Bacterial Adenylyl Cyclases Cyaa and Edema Factor
por: Beste, Kerstin Y., et al.
Publicado: (2013) -
Pharmacological characterization of receptor guanylyl cyclase reporter cell lines
por: Wunder, Frank, et al.
Publicado: (2009) -
Guanylyl cyclase C signaling axis and colon cancer prevention
por: Pattison, Amanda M, et al.
Publicado: (2016) -
Glycosylation of human receptor guanylyl cyclase C
por: Arshad, Najla, et al.
Publicado: (2009) -
Conjoined NO-sensitive guanylyl cyclases
por: Behrends, Sönke, et al.
Publicado: (2011)